Jens Holstein
Director of Finance/CFO presso BIONTECH SE
Patrimonio netto: 765 953 $ in data 29/02/2024
Profilo
Jens Holstein occupa la posizione di direttore finanziario per BioNTech SE. Il sig. Holstein è anche nel consiglio di Veracyte, Inc. Holstein ha precedentemente ricoperto la posizione di Chief Financial Officer di MorphoSys AG, Director-Finance & Labor presso Wittgensteiner Kliniken AG, Commercial Manager-Projects & Service presso Fresenius SE & Co. KGaA Managing Director presso Fresenius ProServe GmbH, Managing Director presso Fresenius Kabi Deutschland GmbH, Chief Financial Officer di Fresenius Kabi Asia Pacific Ltd. e CFO-Europe & Middle East Region presso Fresenius Kabi AG (che sono tutte filiali di Fresenius SE & Co. KGaA), General Manager per Hospitalia Care Gmbh e Commercial Manager presso Hospitalia International GmbH. Jens Holstein si è laureato all'Università di Mnster.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VERACYTE INC
0.03% | 09/06/2023 | 26 405 ( 0.03% ) | 621 838 $ | 29/02/2024 |
BIONTECH SE
0.00% | 31/12/2023 | 1 620 ( 0.00% ) | 144 115 $ | 29/02/2024 |
Posizioni attive di Jens Holstein
Società | Posizione | Inizio |
---|---|---|
VERACYTE, INC. | Director/Board Member | 01/08/2020 |
BIONTECH SE | Director of Finance/CFO | 01/07/2021 |
Precedenti posizioni note di Jens Holstein
Società | Posizione | Fine |
---|---|---|
MORPHOSYS AG | Director of Finance/CFO | 31/12/2020 |
INFLARX N.V. | Director/Board Member | 16/07/2020 |
Fresenius Kabi Asia Pacific Ltd.
Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The private company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients. | Corporate Officer/Principal | 01/01/2010 |
Wittgensteiner Kliniken AG | Director of Finance/CFO | 01/02/2006 |
Hospitalia Care Gmbh | Corporate Officer/Principal | 01/06/2002 |
Formazione di Jens Holstein
University of Münster | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
FRESENIUS SE & CO. KGAA | Health Technology |
VERACYTE, INC. | Health Technology |
MORPHOSYS AG | Health Technology |
BIONTECH SE | Health Technology |
INFLARX N.V. | Health Technology |
Aziende private | 8 |
---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
Wittgensteiner Kliniken AG | Health Services |
Fresenius ProServe GmbH
Fresenius ProServe GmbH Hospital/Nursing ManagementHealth Services Fresenius ProServe GmbH specializes in the medical business with hospitals and healthcare facilities. Its services range from the planning and construction of hospitals to technical and operational management in its core areas of hospital management and hospital engineering. The company is headquartered in Bad Homburg vor der Höhe, Germany. | Health Services |
InflaRx GmbH
InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Health Technology |
Hospitalia International GmbH
Hospitalia International GmbH Medical/Nursing ServicesHealth Services Part of Else Kröner-Fresenius-Stiftung, Hospitalia International GmbH is a German company that provides health care and other related services. The private company is based in Bad Homburg, Germany. The CEOs of the company are Mirsad Midzic, Jens K. Schäkel, Rafael Garcia Feil. | Health Services |
Fresenius Kabi Asia Pacific Ltd.
Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The private company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients. | Distribution Services |
Hospitalia Care Gmbh | |
Fresenius Kabi Deutschland GmbH
Fresenius Kabi Deutschland GmbH Pharmaceuticals: GenericHealth Technology Part of Fresenius SE & Co. KGaA, Fresenius Kabi Deutschland GmbH is a healthcare company based in Bad Homburg vor der Hohe, Germany. The CEOs are Steffen Roser, Christoph Funke, Tanja Greve. Fresenius Kabi creates an environment of mutual respect, encouragement, and teamwork. The German company specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The private company is also specialized in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing & distribution set up. The company has summarized their expectations towards their suppliers and business partners in a suppliers code of conduct and a business partner code of conduct. The company was founded in 1999. | Health Technology |